- Home
- CRIS vs IINN Comparison
CRIS vs IINN Comparison
Compare CRIS & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- IINN
- Stock Information
- Founded
- CRIS 2000
- IINN 2018
- Country
- CRIS United States
- IINN Israel
- Employees
- CRIS N/A
- IINN N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- IINN Medical/Dental Instruments
- Sector
- CRIS Health Care
- IINN Health Care
- Exchange
- CRIS Nasdaq
- IINN Nasdaq
- Market Cap
- CRIS 13.5M
- IINN 15.9M
- IPO Year
- CRIS 2000
- IINN 2021
- Fundamental
- Price
- CRIS $1.96
- IINN $0.56
- Analyst Decision
- CRIS Strong Buy
- IINN
- Analyst Count
- CRIS 3
- IINN 0
- Target Price
- CRIS $21.00
- IINN N/A
- AVG Volume (30 Days)
- CRIS 99.1K
- IINN 412.6K
- Earning Date
- CRIS 05-06-2025
- IINN 05-20-2025
- Dividend Yield
- CRIS N/A
- IINN N/A
- EPS Growth
- CRIS N/A
- IINN N/A
- EPS
- CRIS N/A
- IINN N/A
- Revenue
- CRIS $11,202,000.00
- IINN N/A
- Revenue This Year
- CRIS $4.67
- IINN N/A
- Revenue Next Year
- CRIS $9.77
- IINN N/A
- P/E Ratio
- CRIS N/A
- IINN N/A
- Revenue Growth
- CRIS 14.17
- IINN N/A
- 52 Week Low
- CRIS $1.02
- IINN $0.53
- 52 Week High
- CRIS $16.93
- IINN $2.45
- Technical
- Relative Strength Index (RSI)
- CRIS 50.58
- IINN 38.35
- Support Level
- CRIS $1.85
- IINN $0.57
- Resistance Level
- CRIS $2.25
- IINN $0.67
- Average True Range (ATR)
- CRIS 0.27
- IINN 0.05
- MACD
- CRIS 0.04
- IINN 0.00
- Stochastic Oscillator
- CRIS 41.73
- IINN 26.49
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.